Barclays Reiterates Equal-Weight Rating on Labcorp Holdings Inc. (LH)

Market Context

Labcorp Holdings Inc. operates in the Healthcare sector. The stock currently trades at $306.75 with a market capitalization of $21.9B. The stock has gained 21.4% over the past 52 weeks.

Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Labcorp Holdings Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Labcorp Holdings Inc.

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 31, 2026	Truist Securities	Buy	N/A
Jul 31, 2026	Barclays	Equal-Weight	N/A
Jul 13, 2026	Baird	Outperform	N/A
Jul 13, 2026	B of A Securities	Buy	N/A
Apr 08, 2026	Evercore ISI Group	Outperform	N/A

Related Tools: Analyst Ratings Dashboard | View LH Stock Page